Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients

In Egypt, Sofosbuvir (SOF) in combination with Dataclasvir (DCV) is the broadly used DAAs with excellent therapeutic profile. This study is designed to explore the relation between IL28B/TLR4 genetic variants and each of the followings; HCC development post SOF/DCV treatment, progression to HCC in n...

Full description

Bibliographic Details
Main Authors: Ghada M. Salum, Reham M. Dawood, Mai Abd el-Meguid, Noha E. Ibrahim, Ashraf O. Abdel Aziz, Mostafa K. El Awady
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2020-09-01
Series:Genes and Diseases
Subjects:
DAAs
DCV
HCV
HCC
IL28B
SOF
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304219300352

Internet

http://www.sciencedirect.com/science/article/pii/S2352304219300352

Similar Items